Global Neurovascular Embolic Protection Device Market Growth 2026-2032
The global Neurovascular Embolic Protection Device market size is predicted to grow from US$ 507 million in 2025 to US$ 882 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.
United States market for Neurovascular Embolic Protection Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Neurovascular Embolic Protection Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Neurovascular Embolic Protection Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Neurovascular Embolic Protection Device players cover InspireMD, Inc., Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cardinal Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Neurovascular Embolic Protection Device Industry Forecast” looks at past sales and reviews total world Neurovascular Embolic Protection Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Neurovascular Embolic Protection Device sales for 2026 through 2032. With Neurovascular Embolic Protection Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurovascular Embolic Protection Device industry.
This Insight Report provides a comprehensive analysis of the global Neurovascular Embolic Protection Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurovascular Embolic Protection Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurovascular Embolic Protection Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurovascular Embolic Protection Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurovascular Embolic Protection Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Embolic Protection Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Neurovascular Embolic Protection Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Neurovascular Embolic Protection Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Neurovascular Embolic Protection Device is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Neurovascular Embolic Protection Device players cover InspireMD, Inc., Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cardinal Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Neurovascular Embolic Protection Device Industry Forecast” looks at past sales and reviews total world Neurovascular Embolic Protection Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Neurovascular Embolic Protection Device sales for 2026 through 2032. With Neurovascular Embolic Protection Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurovascular Embolic Protection Device industry.
This Insight Report provides a comprehensive analysis of the global Neurovascular Embolic Protection Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurovascular Embolic Protection Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurovascular Embolic Protection Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurovascular Embolic Protection Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurovascular Embolic Protection Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Embolic Protection Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Distal Occlusion Devices
- Proximal Occlusion Devices
- Distal Filters
- Hospitals & Clinics
- Ambulatoy Surgery Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- InspireMD, Inc.
- Boston Scientific Corporation
- Abbott Laboratories
- Medtronic plc
- Cardinal Health
- Contego Medical, LLC
- Silk Road Medical, Inc.
- Edwards
- Lifesciences Corporation
- Lepu Medical Technology
- What is the 10-year outlook for the global Neurovascular Embolic Protection Device market?
- What factors are driving Neurovascular Embolic Protection Device market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Neurovascular Embolic Protection Device market opportunities vary by end market size?
- How does Neurovascular Embolic Protection Device break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurovascular Embolic Protection Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Neurovascular Embolic Protection Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Neurovascular Embolic Protection Device by Country/Region, 2021, 2025 & 2032
2.2 Neurovascular Embolic Protection Device Segment by Type
2.2.1 Distal Occlusion Devices
2.2.2 Proximal Occlusion Devices
2.2.3 Distal Filters
2.2.4 Neurovascular Embolic Protection Device Sales by Type
2.2.4.1 Global Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
2.2.4.2 Global Neurovascular Embolic Protection Device Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Neurovascular Embolic Protection Device Sale Price by Type (2021-2026)
2.3 Neurovascular Embolic Protection Device Segment by Application
2.3.1 Hospitals & Clinics
2.3.2 Ambulatoy Surgery Centers
2.3.3 Others
2.3.4 Neurovascular Embolic Protection Device Sales by Application
2.3.4.1 Global Neurovascular Embolic Protection Device Sale Market Share by Application (2021-2026)
2.3.4.2 Global Neurovascular Embolic Protection Device Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Neurovascular Embolic Protection Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Neurovascular Embolic Protection Device Breakdown Data by Company
3.1.1 Global Neurovascular Embolic Protection Device Annual Sales by Company (2021-2026)
3.1.2 Global Neurovascular Embolic Protection Device Sales Market Share by Company (2021-2026)
3.2 Global Neurovascular Embolic Protection Device Annual Revenue by Company (2021-2026)
3.2.1 Global Neurovascular Embolic Protection Device Revenue by Company (2021-2026)
3.2.2 Global Neurovascular Embolic Protection Device Revenue Market Share by Company (2021-2026)
3.3 Global Neurovascular Embolic Protection Device Sale Price by Company
3.4 Key Manufacturers Neurovascular Embolic Protection Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurovascular Embolic Protection Device Product Location Distribution
3.4.2 Players Neurovascular Embolic Protection Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROVASCULAR EMBOLIC PROTECTION DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Neurovascular Embolic Protection Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Neurovascular Embolic Protection Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Neurovascular Embolic Protection Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Neurovascular Embolic Protection Device Market Size by Country/Region (2021-2026)
4.2.1 Global Neurovascular Embolic Protection Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Neurovascular Embolic Protection Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neurovascular Embolic Protection Device Sales Growth
4.4 APAC Neurovascular Embolic Protection Device Sales Growth
4.5 Europe Neurovascular Embolic Protection Device Sales Growth
4.6 Middle East & Africa Neurovascular Embolic Protection Device Sales Growth
5 AMERICAS
5.1 Americas Neurovascular Embolic Protection Device Sales by Country
5.1.1 Americas Neurovascular Embolic Protection Device Sales by Country (2021-2026)
5.1.2 Americas Neurovascular Embolic Protection Device Revenue by Country (2021-2026)
5.2 Americas Neurovascular Embolic Protection Device Sales by Type (2021-2026)
5.3 Americas Neurovascular Embolic Protection Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Embolic Protection Device Sales by Region
6.1.1 APAC Neurovascular Embolic Protection Device Sales by Region (2021-2026)
6.1.2 APAC Neurovascular Embolic Protection Device Revenue by Region (2021-2026)
6.2 APAC Neurovascular Embolic Protection Device Sales by Type (2021-2026)
6.3 APAC Neurovascular Embolic Protection Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurovascular Embolic Protection Device by Country
7.1.1 Europe Neurovascular Embolic Protection Device Sales by Country (2021-2026)
7.1.2 Europe Neurovascular Embolic Protection Device Revenue by Country (2021-2026)
7.2 Europe Neurovascular Embolic Protection Device Sales by Type (2021-2026)
7.3 Europe Neurovascular Embolic Protection Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurovascular Embolic Protection Device by Country
8.1.1 Middle East & Africa Neurovascular Embolic Protection Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Neurovascular Embolic Protection Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Neurovascular Embolic Protection Device Sales by Type (2021-2026)
8.3 Middle East & Africa Neurovascular Embolic Protection Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurovascular Embolic Protection Device
10.3 Manufacturing Process Analysis of Neurovascular Embolic Protection Device
10.4 Industry Chain Structure of Neurovascular Embolic Protection Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurovascular Embolic Protection Device Distributors
11.3 Neurovascular Embolic Protection Device Customer
12 WORLD FORECAST REVIEW FOR NEUROVASCULAR EMBOLIC PROTECTION DEVICE BY GEOGRAPHIC REGION
12.1 Global Neurovascular Embolic Protection Device Market Size Forecast by Region
12.1.1 Global Neurovascular Embolic Protection Device Forecast by Region (2027-2032)
12.1.2 Global Neurovascular Embolic Protection Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Neurovascular Embolic Protection Device Forecast by Type (2027-2032)
12.7 Global Neurovascular Embolic Protection Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 InspireMD, Inc.
13.1.1 InspireMD, Inc. Company Information
13.1.2 InspireMD, Inc. Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.1.3 InspireMD, Inc. Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 InspireMD, Inc. Main Business Overview
13.1.5 InspireMD, Inc. Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.3.3 Abbott Laboratories Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Medtronic plc
13.4.1 Medtronic plc Company Information
13.4.2 Medtronic plc Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.4.3 Medtronic plc Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Medtronic plc Main Business Overview
13.4.5 Medtronic plc Latest Developments
13.5 Cardinal Health
13.5.1 Cardinal Health Company Information
13.5.2 Cardinal Health Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.5.3 Cardinal Health Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cardinal Health Main Business Overview
13.5.5 Cardinal Health Latest Developments
13.6 Contego Medical, LLC
13.6.1 Contego Medical, LLC Company Information
13.6.2 Contego Medical, LLC Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.6.3 Contego Medical, LLC Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Contego Medical, LLC Main Business Overview
13.6.5 Contego Medical, LLC Latest Developments
13.7 Silk Road Medical, Inc.
13.7.1 Silk Road Medical, Inc. Company Information
13.7.2 Silk Road Medical, Inc. Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.7.3 Silk Road Medical, Inc. Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Silk Road Medical, Inc. Main Business Overview
13.7.5 Silk Road Medical, Inc. Latest Developments
13.8 Edwards
13.8.1 Edwards Company Information
13.8.2 Edwards Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.8.3 Edwards Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Edwards Main Business Overview
13.8.5 Edwards Latest Developments
13.9 Lifesciences Corporation
13.9.1 Lifesciences Corporation Company Information
13.9.2 Lifesciences Corporation Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.9.3 Lifesciences Corporation Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Lifesciences Corporation Main Business Overview
13.9.5 Lifesciences Corporation Latest Developments
13.10 Lepu Medical Technology
13.10.1 Lepu Medical Technology Company Information
13.10.2 Lepu Medical Technology Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.10.3 Lepu Medical Technology Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lepu Medical Technology Main Business Overview
13.10.5 Lepu Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurovascular Embolic Protection Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Neurovascular Embolic Protection Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Neurovascular Embolic Protection Device by Country/Region, 2021, 2025 & 2032
2.2 Neurovascular Embolic Protection Device Segment by Type
2.2.1 Distal Occlusion Devices
2.2.2 Proximal Occlusion Devices
2.2.3 Distal Filters
2.2.4 Neurovascular Embolic Protection Device Sales by Type
2.2.4.1 Global Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
2.2.4.2 Global Neurovascular Embolic Protection Device Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Neurovascular Embolic Protection Device Sale Price by Type (2021-2026)
2.3 Neurovascular Embolic Protection Device Segment by Application
2.3.1 Hospitals & Clinics
2.3.2 Ambulatoy Surgery Centers
2.3.3 Others
2.3.4 Neurovascular Embolic Protection Device Sales by Application
2.3.4.1 Global Neurovascular Embolic Protection Device Sale Market Share by Application (2021-2026)
2.3.4.2 Global Neurovascular Embolic Protection Device Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Neurovascular Embolic Protection Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Neurovascular Embolic Protection Device Breakdown Data by Company
3.1.1 Global Neurovascular Embolic Protection Device Annual Sales by Company (2021-2026)
3.1.2 Global Neurovascular Embolic Protection Device Sales Market Share by Company (2021-2026)
3.2 Global Neurovascular Embolic Protection Device Annual Revenue by Company (2021-2026)
3.2.1 Global Neurovascular Embolic Protection Device Revenue by Company (2021-2026)
3.2.2 Global Neurovascular Embolic Protection Device Revenue Market Share by Company (2021-2026)
3.3 Global Neurovascular Embolic Protection Device Sale Price by Company
3.4 Key Manufacturers Neurovascular Embolic Protection Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurovascular Embolic Protection Device Product Location Distribution
3.4.2 Players Neurovascular Embolic Protection Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROVASCULAR EMBOLIC PROTECTION DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Neurovascular Embolic Protection Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Neurovascular Embolic Protection Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Neurovascular Embolic Protection Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Neurovascular Embolic Protection Device Market Size by Country/Region (2021-2026)
4.2.1 Global Neurovascular Embolic Protection Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Neurovascular Embolic Protection Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neurovascular Embolic Protection Device Sales Growth
4.4 APAC Neurovascular Embolic Protection Device Sales Growth
4.5 Europe Neurovascular Embolic Protection Device Sales Growth
4.6 Middle East & Africa Neurovascular Embolic Protection Device Sales Growth
5 AMERICAS
5.1 Americas Neurovascular Embolic Protection Device Sales by Country
5.1.1 Americas Neurovascular Embolic Protection Device Sales by Country (2021-2026)
5.1.2 Americas Neurovascular Embolic Protection Device Revenue by Country (2021-2026)
5.2 Americas Neurovascular Embolic Protection Device Sales by Type (2021-2026)
5.3 Americas Neurovascular Embolic Protection Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Embolic Protection Device Sales by Region
6.1.1 APAC Neurovascular Embolic Protection Device Sales by Region (2021-2026)
6.1.2 APAC Neurovascular Embolic Protection Device Revenue by Region (2021-2026)
6.2 APAC Neurovascular Embolic Protection Device Sales by Type (2021-2026)
6.3 APAC Neurovascular Embolic Protection Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurovascular Embolic Protection Device by Country
7.1.1 Europe Neurovascular Embolic Protection Device Sales by Country (2021-2026)
7.1.2 Europe Neurovascular Embolic Protection Device Revenue by Country (2021-2026)
7.2 Europe Neurovascular Embolic Protection Device Sales by Type (2021-2026)
7.3 Europe Neurovascular Embolic Protection Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurovascular Embolic Protection Device by Country
8.1.1 Middle East & Africa Neurovascular Embolic Protection Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Neurovascular Embolic Protection Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Neurovascular Embolic Protection Device Sales by Type (2021-2026)
8.3 Middle East & Africa Neurovascular Embolic Protection Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurovascular Embolic Protection Device
10.3 Manufacturing Process Analysis of Neurovascular Embolic Protection Device
10.4 Industry Chain Structure of Neurovascular Embolic Protection Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurovascular Embolic Protection Device Distributors
11.3 Neurovascular Embolic Protection Device Customer
12 WORLD FORECAST REVIEW FOR NEUROVASCULAR EMBOLIC PROTECTION DEVICE BY GEOGRAPHIC REGION
12.1 Global Neurovascular Embolic Protection Device Market Size Forecast by Region
12.1.1 Global Neurovascular Embolic Protection Device Forecast by Region (2027-2032)
12.1.2 Global Neurovascular Embolic Protection Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Neurovascular Embolic Protection Device Forecast by Type (2027-2032)
12.7 Global Neurovascular Embolic Protection Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 InspireMD, Inc.
13.1.1 InspireMD, Inc. Company Information
13.1.2 InspireMD, Inc. Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.1.3 InspireMD, Inc. Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 InspireMD, Inc. Main Business Overview
13.1.5 InspireMD, Inc. Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.3.3 Abbott Laboratories Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Medtronic plc
13.4.1 Medtronic plc Company Information
13.4.2 Medtronic plc Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.4.3 Medtronic plc Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Medtronic plc Main Business Overview
13.4.5 Medtronic plc Latest Developments
13.5 Cardinal Health
13.5.1 Cardinal Health Company Information
13.5.2 Cardinal Health Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.5.3 Cardinal Health Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cardinal Health Main Business Overview
13.5.5 Cardinal Health Latest Developments
13.6 Contego Medical, LLC
13.6.1 Contego Medical, LLC Company Information
13.6.2 Contego Medical, LLC Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.6.3 Contego Medical, LLC Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Contego Medical, LLC Main Business Overview
13.6.5 Contego Medical, LLC Latest Developments
13.7 Silk Road Medical, Inc.
13.7.1 Silk Road Medical, Inc. Company Information
13.7.2 Silk Road Medical, Inc. Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.7.3 Silk Road Medical, Inc. Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Silk Road Medical, Inc. Main Business Overview
13.7.5 Silk Road Medical, Inc. Latest Developments
13.8 Edwards
13.8.1 Edwards Company Information
13.8.2 Edwards Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.8.3 Edwards Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Edwards Main Business Overview
13.8.5 Edwards Latest Developments
13.9 Lifesciences Corporation
13.9.1 Lifesciences Corporation Company Information
13.9.2 Lifesciences Corporation Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.9.3 Lifesciences Corporation Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Lifesciences Corporation Main Business Overview
13.9.5 Lifesciences Corporation Latest Developments
13.10 Lepu Medical Technology
13.10.1 Lepu Medical Technology Company Information
13.10.2 Lepu Medical Technology Neurovascular Embolic Protection Device Product Portfolios and Specifications
13.10.3 Lepu Medical Technology Neurovascular Embolic Protection Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lepu Medical Technology Main Business Overview
13.10.5 Lepu Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurovascular Embolic Protection Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Neurovascular Embolic Protection Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Distal Occlusion Devices
Table 4. Major Players of Proximal Occlusion Devices
Table 5. Major Players of Distal Filters
Table 6. Global Neurovascular Embolic Protection Device Sales by Type (2021-2026) & (K Units)
Table 7. Global Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
Table 8. Global Neurovascular Embolic Protection Device Revenue by Type (2021-2026) & ($ million)
Table 9. Global Neurovascular Embolic Protection Device Revenue Market Share by Type (2021-2026)
Table 10. Global Neurovascular Embolic Protection Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Neurovascular Embolic Protection Device Sale by Application (2021-2026) & (K Units)
Table 12. Global Neurovascular Embolic Protection Device Sale Market Share by Application (2021-2026)
Table 13. Global Neurovascular Embolic Protection Device Revenue by Application (2021-2026) & ($ million)
Table 14. Global Neurovascular Embolic Protection Device Revenue Market Share by Application (2021-2026)
Table 15. Global Neurovascular Embolic Protection Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Neurovascular Embolic Protection Device Sales by Company (2021-2026) & (K Units)
Table 17. Global Neurovascular Embolic Protection Device Sales Market Share by Company (2021-2026)
Table 18. Global Neurovascular Embolic Protection Device Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Neurovascular Embolic Protection Device Revenue Market Share by Company (2021-2026)
Table 20. Global Neurovascular Embolic Protection Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Neurovascular Embolic Protection Device Producing Area Distribution and Sales Area
Table 22. Players Neurovascular Embolic Protection Device Products Offered
Table 23. Neurovascular Embolic Protection Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Neurovascular Embolic Protection Device Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Neurovascular Embolic Protection Device Sales Market Share Geographic Region (2021-2026)
Table 28. Global Neurovascular Embolic Protection Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Neurovascular Embolic Protection Device Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Neurovascular Embolic Protection Device Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Neurovascular Embolic Protection Device Sales Market Share by Country/Region (2021-2026)
Table 32. Global Neurovascular Embolic Protection Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Neurovascular Embolic Protection Device Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Neurovascular Embolic Protection Device Sales by Country (2021-2026) & (K Units)
Table 35. Americas Neurovascular Embolic Protection Device Sales Market Share by Country (2021-2026)
Table 36. Americas Neurovascular Embolic Protection Device Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Neurovascular Embolic Protection Device Sales by Type (2021-2026) & (K Units)
Table 38. Americas Neurovascular Embolic Protection Device Sales by Application (2021-2026) & (K Units)
Table 39. APAC Neurovascular Embolic Protection Device Sales by Region (2021-2026) & (K Units)
Table 40. APAC Neurovascular Embolic Protection Device Sales Market Share by Region (2021-2026)
Table 41. APAC Neurovascular Embolic Protection Device Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Neurovascular Embolic Protection Device Sales by Type (2021-2026) & (K Units)
Table 43. APAC Neurovascular Embolic Protection Device Sales by Application (2021-2026) & (K Units)
Table 44. Europe Neurovascular Embolic Protection Device Sales by Country (2021-2026) & (K Units)
Table 45. Europe Neurovascular Embolic Protection Device Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Neurovascular Embolic Protection Device Sales by Type (2021-2026) & (K Units)
Table 47. Europe Neurovascular Embolic Protection Device Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Neurovascular Embolic Protection Device Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Neurovascular Embolic Protection Device Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Neurovascular Embolic Protection Device Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Neurovascular Embolic Protection Device Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Neurovascular Embolic Protection Device
Table 53. Key Market Challenges & Risks of Neurovascular Embolic Protection Device
Table 54. Key Industry Trends of Neurovascular Embolic Protection Device
Table 55. Neurovascular Embolic Protection Device Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Neurovascular Embolic Protection Device Distributors List
Table 58. Neurovascular Embolic Protection Device Customer List
Table 59. Global Neurovascular Embolic Protection Device Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Neurovascular Embolic Protection Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Neurovascular Embolic Protection Device Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Neurovascular Embolic Protection Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Neurovascular Embolic Protection Device Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Neurovascular Embolic Protection Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Neurovascular Embolic Protection Device Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Neurovascular Embolic Protection Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Neurovascular Embolic Protection Device Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Neurovascular Embolic Protection Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Neurovascular Embolic Protection Device Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Neurovascular Embolic Protection Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Neurovascular Embolic Protection Device Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Neurovascular Embolic Protection Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. InspireMD, Inc. Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 74. InspireMD, Inc. Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 75. InspireMD, Inc. Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. InspireMD, Inc. Main Business
Table 77. InspireMD, Inc. Latest Developments
Table 78. Boston Scientific Corporation Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 79. Boston Scientific Corporation Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 80. Boston Scientific Corporation Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Boston Scientific Corporation Main Business
Table 82. Boston Scientific Corporation Latest Developments
Table 83. Abbott Laboratories Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 84. Abbott Laboratories Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 85. Abbott Laboratories Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Abbott Laboratories Main Business
Table 87. Abbott Laboratories Latest Developments
Table 88. Medtronic plc Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 89. Medtronic plc Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 90. Medtronic plc Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Medtronic plc Main Business
Table 92. Medtronic plc Latest Developments
Table 93. Cardinal Health Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Cardinal Health Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 95. Cardinal Health Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Cardinal Health Main Business
Table 97. Cardinal Health Latest Developments
Table 98. Contego Medical, LLC Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Contego Medical, LLC Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 100. Contego Medical, LLC Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Contego Medical, LLC Main Business
Table 102. Contego Medical, LLC Latest Developments
Table 103. Silk Road Medical, Inc. Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 104. Silk Road Medical, Inc. Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 105. Silk Road Medical, Inc. Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Silk Road Medical, Inc. Main Business
Table 107. Silk Road Medical, Inc. Latest Developments
Table 108. Edwards Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 109. Edwards Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 110. Edwards Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Edwards Main Business
Table 112. Edwards Latest Developments
Table 113. Lifesciences Corporation Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Lifesciences Corporation Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 115. Lifesciences Corporation Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lifesciences Corporation Main Business
Table 117. Lifesciences Corporation Latest Developments
Table 118. Lepu Medical Technology Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Lepu Medical Technology Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 120. Lepu Medical Technology Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Lepu Medical Technology Main Business
Table 122. Lepu Medical Technology Latest Developments
Table 1. Neurovascular Embolic Protection Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Neurovascular Embolic Protection Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Distal Occlusion Devices
Table 4. Major Players of Proximal Occlusion Devices
Table 5. Major Players of Distal Filters
Table 6. Global Neurovascular Embolic Protection Device Sales by Type (2021-2026) & (K Units)
Table 7. Global Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
Table 8. Global Neurovascular Embolic Protection Device Revenue by Type (2021-2026) & ($ million)
Table 9. Global Neurovascular Embolic Protection Device Revenue Market Share by Type (2021-2026)
Table 10. Global Neurovascular Embolic Protection Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Neurovascular Embolic Protection Device Sale by Application (2021-2026) & (K Units)
Table 12. Global Neurovascular Embolic Protection Device Sale Market Share by Application (2021-2026)
Table 13. Global Neurovascular Embolic Protection Device Revenue by Application (2021-2026) & ($ million)
Table 14. Global Neurovascular Embolic Protection Device Revenue Market Share by Application (2021-2026)
Table 15. Global Neurovascular Embolic Protection Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Neurovascular Embolic Protection Device Sales by Company (2021-2026) & (K Units)
Table 17. Global Neurovascular Embolic Protection Device Sales Market Share by Company (2021-2026)
Table 18. Global Neurovascular Embolic Protection Device Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Neurovascular Embolic Protection Device Revenue Market Share by Company (2021-2026)
Table 20. Global Neurovascular Embolic Protection Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Neurovascular Embolic Protection Device Producing Area Distribution and Sales Area
Table 22. Players Neurovascular Embolic Protection Device Products Offered
Table 23. Neurovascular Embolic Protection Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Neurovascular Embolic Protection Device Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Neurovascular Embolic Protection Device Sales Market Share Geographic Region (2021-2026)
Table 28. Global Neurovascular Embolic Protection Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Neurovascular Embolic Protection Device Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Neurovascular Embolic Protection Device Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Neurovascular Embolic Protection Device Sales Market Share by Country/Region (2021-2026)
Table 32. Global Neurovascular Embolic Protection Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Neurovascular Embolic Protection Device Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Neurovascular Embolic Protection Device Sales by Country (2021-2026) & (K Units)
Table 35. Americas Neurovascular Embolic Protection Device Sales Market Share by Country (2021-2026)
Table 36. Americas Neurovascular Embolic Protection Device Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Neurovascular Embolic Protection Device Sales by Type (2021-2026) & (K Units)
Table 38. Americas Neurovascular Embolic Protection Device Sales by Application (2021-2026) & (K Units)
Table 39. APAC Neurovascular Embolic Protection Device Sales by Region (2021-2026) & (K Units)
Table 40. APAC Neurovascular Embolic Protection Device Sales Market Share by Region (2021-2026)
Table 41. APAC Neurovascular Embolic Protection Device Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Neurovascular Embolic Protection Device Sales by Type (2021-2026) & (K Units)
Table 43. APAC Neurovascular Embolic Protection Device Sales by Application (2021-2026) & (K Units)
Table 44. Europe Neurovascular Embolic Protection Device Sales by Country (2021-2026) & (K Units)
Table 45. Europe Neurovascular Embolic Protection Device Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Neurovascular Embolic Protection Device Sales by Type (2021-2026) & (K Units)
Table 47. Europe Neurovascular Embolic Protection Device Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Neurovascular Embolic Protection Device Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Neurovascular Embolic Protection Device Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Neurovascular Embolic Protection Device Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Neurovascular Embolic Protection Device Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Neurovascular Embolic Protection Device
Table 53. Key Market Challenges & Risks of Neurovascular Embolic Protection Device
Table 54. Key Industry Trends of Neurovascular Embolic Protection Device
Table 55. Neurovascular Embolic Protection Device Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Neurovascular Embolic Protection Device Distributors List
Table 58. Neurovascular Embolic Protection Device Customer List
Table 59. Global Neurovascular Embolic Protection Device Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Neurovascular Embolic Protection Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Neurovascular Embolic Protection Device Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Neurovascular Embolic Protection Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Neurovascular Embolic Protection Device Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Neurovascular Embolic Protection Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Neurovascular Embolic Protection Device Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Neurovascular Embolic Protection Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Neurovascular Embolic Protection Device Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Neurovascular Embolic Protection Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Neurovascular Embolic Protection Device Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Neurovascular Embolic Protection Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Neurovascular Embolic Protection Device Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Neurovascular Embolic Protection Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. InspireMD, Inc. Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 74. InspireMD, Inc. Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 75. InspireMD, Inc. Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. InspireMD, Inc. Main Business
Table 77. InspireMD, Inc. Latest Developments
Table 78. Boston Scientific Corporation Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 79. Boston Scientific Corporation Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 80. Boston Scientific Corporation Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Boston Scientific Corporation Main Business
Table 82. Boston Scientific Corporation Latest Developments
Table 83. Abbott Laboratories Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 84. Abbott Laboratories Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 85. Abbott Laboratories Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Abbott Laboratories Main Business
Table 87. Abbott Laboratories Latest Developments
Table 88. Medtronic plc Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 89. Medtronic plc Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 90. Medtronic plc Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Medtronic plc Main Business
Table 92. Medtronic plc Latest Developments
Table 93. Cardinal Health Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Cardinal Health Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 95. Cardinal Health Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Cardinal Health Main Business
Table 97. Cardinal Health Latest Developments
Table 98. Contego Medical, LLC Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Contego Medical, LLC Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 100. Contego Medical, LLC Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Contego Medical, LLC Main Business
Table 102. Contego Medical, LLC Latest Developments
Table 103. Silk Road Medical, Inc. Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 104. Silk Road Medical, Inc. Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 105. Silk Road Medical, Inc. Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Silk Road Medical, Inc. Main Business
Table 107. Silk Road Medical, Inc. Latest Developments
Table 108. Edwards Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 109. Edwards Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 110. Edwards Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Edwards Main Business
Table 112. Edwards Latest Developments
Table 113. Lifesciences Corporation Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Lifesciences Corporation Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 115. Lifesciences Corporation Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lifesciences Corporation Main Business
Table 117. Lifesciences Corporation Latest Developments
Table 118. Lepu Medical Technology Basic Information, Neurovascular Embolic Protection Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Lepu Medical Technology Neurovascular Embolic Protection Device Product Portfolios and Specifications
Table 120. Lepu Medical Technology Neurovascular Embolic Protection Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Lepu Medical Technology Main Business
Table 122. Lepu Medical Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neurovascular Embolic Protection Device
Figure 2. Neurovascular Embolic Protection Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurovascular Embolic Protection Device Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Neurovascular Embolic Protection Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Neurovascular Embolic Protection Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Neurovascular Embolic Protection Device Sales Market Share by Country/Region (2025)
Figure 10. Neurovascular Embolic Protection Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Distal Occlusion Devices
Figure 12. Product Picture of Proximal Occlusion Devices
Figure 13. Product Picture of Distal Filters
Figure 14. Global Neurovascular Embolic Protection Device Sales Market Share by Type in 2026
Figure 15. Global Neurovascular Embolic Protection Device Revenue Market Share by Type (2021-2026)
Figure 16. Neurovascular Embolic Protection Device Consumed in Hospitals & Clinics
Figure 17. Global Neurovascular Embolic Protection Device Market: Hospitals & Clinics (2021-2026) & (K Units)
Figure 18. Neurovascular Embolic Protection Device Consumed in Ambulatoy Surgery Centers
Figure 19. Global Neurovascular Embolic Protection Device Market: Ambulatoy Surgery Centers (2021-2026) & (K Units)
Figure 20. Neurovascular Embolic Protection Device Consumed in Others
Figure 21. Global Neurovascular Embolic Protection Device Market: Others (2021-2026) & (K Units)
Figure 22. Global Neurovascular Embolic Protection Device Sale Market Share by Application (2025)
Figure 23. Global Neurovascular Embolic Protection Device Revenue Market Share by Application in 2026
Figure 24. Neurovascular Embolic Protection Device Sales by Company in 2026 (K Units)
Figure 25. Global Neurovascular Embolic Protection Device Sales Market Share by Company in 2026
Figure 26. Neurovascular Embolic Protection Device Revenue by Company in 2026 ($ millions)
Figure 27. Global Neurovascular Embolic Protection Device Revenue Market Share by Company in 2026
Figure 28. Global Neurovascular Embolic Protection Device Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Neurovascular Embolic Protection Device Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Neurovascular Embolic Protection Device Sales 2021-2026 (K Units)
Figure 31. Americas Neurovascular Embolic Protection Device Revenue 2021-2026 ($ millions)
Figure 32. APAC Neurovascular Embolic Protection Device Sales 2021-2026 (K Units)
Figure 33. APAC Neurovascular Embolic Protection Device Revenue 2021-2026 ($ millions)
Figure 34. Europe Neurovascular Embolic Protection Device Sales 2021-2026 (K Units)
Figure 35. Europe Neurovascular Embolic Protection Device Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Neurovascular Embolic Protection Device Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Neurovascular Embolic Protection Device Revenue 2021-2026 ($ millions)
Figure 38. Americas Neurovascular Embolic Protection Device Sales Market Share by Country in 2026
Figure 39. Americas Neurovascular Embolic Protection Device Revenue Market Share by Country (2021-2026)
Figure 40. Americas Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
Figure 41. Americas Neurovascular Embolic Protection Device Sales Market Share by Application (2021-2026)
Figure 42. United States Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Neurovascular Embolic Protection Device Sales Market Share by Region in 2026
Figure 47. APAC Neurovascular Embolic Protection Device Revenue Market Share by Region (2021-2026)
Figure 48. APAC Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
Figure 49. APAC Neurovascular Embolic Protection Device Sales Market Share by Application (2021-2026)
Figure 50. China Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 54. India Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Neurovascular Embolic Protection Device Sales Market Share by Country in 2026
Figure 58. Europe Neurovascular Embolic Protection Device Revenue Market Share by Country (2021-2026)
Figure 59. Europe Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
Figure 60. Europe Neurovascular Embolic Protection Device Sales Market Share by Application (2021-2026)
Figure 61. Germany Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 62. France Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Neurovascular Embolic Protection Device Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Neurovascular Embolic Protection Device Sales Market Share by Application (2021-2026)
Figure 69. Egypt Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Neurovascular Embolic Protection Device in 2026
Figure 75. Manufacturing Process Analysis of Neurovascular Embolic Protection Device
Figure 76. Industry Chain Structure of Neurovascular Embolic Protection Device
Figure 77. Channels of Distribution
Figure 78. Global Neurovascular Embolic Protection Device Sales Market Forecast by Region (2027-2032)
Figure 79. Global Neurovascular Embolic Protection Device Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Neurovascular Embolic Protection Device Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Neurovascular Embolic Protection Device Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Neurovascular Embolic Protection Device Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Neurovascular Embolic Protection Device Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Neurovascular Embolic Protection Device
Figure 2. Neurovascular Embolic Protection Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurovascular Embolic Protection Device Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Neurovascular Embolic Protection Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Neurovascular Embolic Protection Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Neurovascular Embolic Protection Device Sales Market Share by Country/Region (2025)
Figure 10. Neurovascular Embolic Protection Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Distal Occlusion Devices
Figure 12. Product Picture of Proximal Occlusion Devices
Figure 13. Product Picture of Distal Filters
Figure 14. Global Neurovascular Embolic Protection Device Sales Market Share by Type in 2026
Figure 15. Global Neurovascular Embolic Protection Device Revenue Market Share by Type (2021-2026)
Figure 16. Neurovascular Embolic Protection Device Consumed in Hospitals & Clinics
Figure 17. Global Neurovascular Embolic Protection Device Market: Hospitals & Clinics (2021-2026) & (K Units)
Figure 18. Neurovascular Embolic Protection Device Consumed in Ambulatoy Surgery Centers
Figure 19. Global Neurovascular Embolic Protection Device Market: Ambulatoy Surgery Centers (2021-2026) & (K Units)
Figure 20. Neurovascular Embolic Protection Device Consumed in Others
Figure 21. Global Neurovascular Embolic Protection Device Market: Others (2021-2026) & (K Units)
Figure 22. Global Neurovascular Embolic Protection Device Sale Market Share by Application (2025)
Figure 23. Global Neurovascular Embolic Protection Device Revenue Market Share by Application in 2026
Figure 24. Neurovascular Embolic Protection Device Sales by Company in 2026 (K Units)
Figure 25. Global Neurovascular Embolic Protection Device Sales Market Share by Company in 2026
Figure 26. Neurovascular Embolic Protection Device Revenue by Company in 2026 ($ millions)
Figure 27. Global Neurovascular Embolic Protection Device Revenue Market Share by Company in 2026
Figure 28. Global Neurovascular Embolic Protection Device Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Neurovascular Embolic Protection Device Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Neurovascular Embolic Protection Device Sales 2021-2026 (K Units)
Figure 31. Americas Neurovascular Embolic Protection Device Revenue 2021-2026 ($ millions)
Figure 32. APAC Neurovascular Embolic Protection Device Sales 2021-2026 (K Units)
Figure 33. APAC Neurovascular Embolic Protection Device Revenue 2021-2026 ($ millions)
Figure 34. Europe Neurovascular Embolic Protection Device Sales 2021-2026 (K Units)
Figure 35. Europe Neurovascular Embolic Protection Device Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Neurovascular Embolic Protection Device Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Neurovascular Embolic Protection Device Revenue 2021-2026 ($ millions)
Figure 38. Americas Neurovascular Embolic Protection Device Sales Market Share by Country in 2026
Figure 39. Americas Neurovascular Embolic Protection Device Revenue Market Share by Country (2021-2026)
Figure 40. Americas Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
Figure 41. Americas Neurovascular Embolic Protection Device Sales Market Share by Application (2021-2026)
Figure 42. United States Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Neurovascular Embolic Protection Device Sales Market Share by Region in 2026
Figure 47. APAC Neurovascular Embolic Protection Device Revenue Market Share by Region (2021-2026)
Figure 48. APAC Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
Figure 49. APAC Neurovascular Embolic Protection Device Sales Market Share by Application (2021-2026)
Figure 50. China Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 54. India Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Neurovascular Embolic Protection Device Sales Market Share by Country in 2026
Figure 58. Europe Neurovascular Embolic Protection Device Revenue Market Share by Country (2021-2026)
Figure 59. Europe Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
Figure 60. Europe Neurovascular Embolic Protection Device Sales Market Share by Application (2021-2026)
Figure 61. Germany Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 62. France Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Neurovascular Embolic Protection Device Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Neurovascular Embolic Protection Device Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Neurovascular Embolic Protection Device Sales Market Share by Application (2021-2026)
Figure 69. Egypt Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Neurovascular Embolic Protection Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Neurovascular Embolic Protection Device in 2026
Figure 75. Manufacturing Process Analysis of Neurovascular Embolic Protection Device
Figure 76. Industry Chain Structure of Neurovascular Embolic Protection Device
Figure 77. Channels of Distribution
Figure 78. Global Neurovascular Embolic Protection Device Sales Market Forecast by Region (2027-2032)
Figure 79. Global Neurovascular Embolic Protection Device Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Neurovascular Embolic Protection Device Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Neurovascular Embolic Protection Device Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Neurovascular Embolic Protection Device Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Neurovascular Embolic Protection Device Revenue Market Share Forecast by Application (2027-2032)
